🇺🇸 FDA
Patent

US 10675258

Method of using gamma-hydroxybutyrate compositions for the treatment of disorders

granted A61KA61K31/19A61K31/554

Quick answer

US patent 10675258 (Method of using gamma-hydroxybutyrate compositions for the treatment of disorders) held by Jazz Pharmaceuticals Ireland Limited expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals Ireland Limited
Grant date
Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K31/19, A61K31/554, A61K9/0053, A61K9/08